| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 2.7e-05 | 1 |